IL90996A - S-adenosyl-methionine decarboxylase inhibitors, method for their preparation and pharmaceutical compositions containing them - Google Patents

S-adenosyl-methionine decarboxylase inhibitors, method for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL90996A
IL90996A IL9099689A IL9099689A IL90996A IL 90996 A IL90996 A IL 90996A IL 9099689 A IL9099689 A IL 9099689A IL 9099689 A IL9099689 A IL 9099689A IL 90996 A IL90996 A IL 90996A
Authority
IL
Israel
Prior art keywords
compound
deoxy
mmol
amino
cis
Prior art date
Application number
IL9099689A
Other languages
English (en)
Other versions
IL90996A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88401896A external-priority patent/EP0351475A1/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL90996A0 publication Critical patent/IL90996A0/xx
Publication of IL90996A publication Critical patent/IL90996A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL9099689A 1988-07-21 1989-07-17 S-adenosyl-methionine decarboxylase inhibitors, method for their preparation and pharmaceutical compositions containing them IL90996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88401896A EP0351475A1 (en) 1988-07-21 1988-07-21 S-Adenosylmethionine decarboxylase inhibitors
EP89401845A EP0358536B1 (en) 1988-07-21 1989-06-28 Novel S-adenosyl methionine decarboxylase inhibitors

Publications (2)

Publication Number Publication Date
IL90996A0 IL90996A0 (en) 1990-02-09
IL90996A true IL90996A (en) 1994-11-28

Family

ID=26117870

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9099689A IL90996A (en) 1988-07-21 1989-07-17 S-adenosyl-methionine decarboxylase inhibitors, method for their preparation and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0358536B1 (da)
JP (1) JP2789228B2 (da)
KR (1) KR0150633B1 (da)
CN (1) CN1026115C (da)
CA (1) CA1335201C (da)
DK (1) DK171027B1 (da)
FI (1) FI94644C (da)
IE (1) IE81169B1 (da)
IL (1) IL90996A (da)
NO (1) NO171982C (da)
NZ (1) NZ229955A (da)
PT (1) PT91235B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA916464B (en) * 1990-08-22 1992-05-27 Merrell Dow Pharma 5'-amine substituted adenosine analogs as immunosuppressants
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
EP1221615A2 (en) 1995-04-25 2002-07-10 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
KR100456970B1 (ko) * 2001-12-31 2004-11-10 주식회사 디피아이 우레탄 변성 폴리에스테르 수지 조성물, 이의 제조 방법및 이를 포함하는 도료 조성물
KR100496049B1 (ko) * 2001-12-31 2005-06-17 주식회사 디피아이 열경화성 우레탄 변성 폴리에스테르 수지 조성물
EP1408028A1 (en) * 2002-10-09 2004-04-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection
JP2010535202A (ja) * 2007-08-02 2010-11-18 サザン リサーチ インスティテュート 5’−置換アデノシン、その製造、及び、s−アデノシルメチオニン脱炭酸酵素の阻害剤としての使用

Also Published As

Publication number Publication date
PT91235A (pt) 1990-02-08
KR910002891A (ko) 1991-02-26
IE81169B1 (en) 2000-05-31
JP2789228B2 (ja) 1998-08-20
AU3886689A (en) 1990-02-01
NZ229955A (en) 1991-03-26
PT91235B (pt) 1995-03-01
JPH02191296A (ja) 1990-07-27
FI893507A0 (fi) 1989-07-20
IL90996A0 (en) 1990-02-09
EP0358536A3 (en) 1991-04-03
CN1039422A (zh) 1990-02-07
CA1335201C (en) 1995-04-11
NO892977D0 (no) 1989-07-20
IE892364L (en) 1990-01-21
FI893507A7 (fi) 1990-01-22
EP0358536A2 (en) 1990-03-14
NO171982C (no) 1993-05-26
DK360189A (da) 1990-01-22
EP0358536B1 (en) 1996-05-08
CN1026115C (zh) 1994-10-05
KR0150633B1 (ko) 1998-08-17
DK171027B1 (da) 1996-04-22
DK360189D0 (da) 1989-07-20
FI94644B (fi) 1995-06-30
NO171982B (no) 1993-02-15
FI94644C (fi) 1995-10-10
AU610740B2 (en) 1991-05-23
NO892977L (no) 1990-01-22

Similar Documents

Publication Publication Date Title
FI67369B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva derivat av 3,4-dehydroprolin
EP0184365B1 (en) Improvements in the treatment of tumors in mammals
US4330559A (en) Method of treating benign prostatic hypertrophy
CA1335201C (en) S-adenosyl methionine inhibitors
US5416076A (en) S-adenosyl methionine decarboxylase inhibitors
HU202550B (en) Process for producing 2-substituted adenosyl derivatives and pharmaceutical compositions comprising such compounds
US4439619A (en) Fluorinated pentene diamine derivatives
NZ226274A (en) Saccharide derivatives; pharmaceutical compositions and preparatory processes
US4707498A (en) Fluorinated diaminoalkyne derivatives
EP0072761B1 (en) Decarboxylase-inhibiting fluorinated alkane diamine derivatives
CA1204770A (en) Fluorinated diaminoalkene derivatives
IE54304B1 (en) Fluorinated diamino-heptene and -heptyne derivatives
JPH0251422B2 (da)
GB2104060A (en) Fluorinated hexene diamine derivatives
GB2126577A (en) Fluorinated diamino-octene and octyne derivatives
WO1993018771A1 (en) PLATELET AGGLUTINATION INHIBITOR CONTAINING STAUROSPORINE η-LACTAM DERIVATIVE

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.